Information Update - UPDATE: Auro Pharma Inc., Pharmascience Inc. and Sivem Pharmaceuticals ULC recall multiple lots of losartan

·6 min read

OTTAWA, ON, Oct. 15, 2021 /CNW/ - Auro Pharma Inc., Pharmascience Inc., and Sivem Pharmaceuticals ULC are recalling multiple lots of prescription losartan tablets, in 25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit. Long-term exposure to the impurity at levels above what is considered safe could potentially increase the risk of cancer.

Please see the full advisory for more information, including what Canadians should do and Health Canada's work to address the issue of azido impurities found in certain drugs.

Product

Company

DIN

Lot

Expiry

AURO-LOSARTAN HCT 50/12.5 mg

Auro Pharma Inc.

02423642

ACI5021007B

05 February 2024

AURO-LOSARTAN HCT 50/12.5 mg

Auro Pharma Inc.

02423642

QX5019009-C

05 December 2022

AURO-LOSARTAN HCT 50/12.5 mg

Auro Pharma Inc.

02423642

QX5019009-B

05 December 2022

AURO-LOSARTAN HCT 50/12.5 mg

Auro Pharma Inc.

02423642

QX5019010-A

05 December 2022

AURO-LOSARTAN HCT 50/12.5 mg

Auro Pharma Inc.

02423642

QX5019011-B

12 December 2022

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

ACO1021003A

16 February 2024

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018013-A

04 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018015-A

04 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018012-A

04 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018010-A

03 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018012-B

04 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018014-A

04 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1018011-A

03 December 2021

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1019009-D

02 December 2022

AURO-LOSARTAN HCT 100/12.5 mg

Auro Pharma Inc.

02423650

QY1019009-A

02 December 2022

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

QX1019007-A

24 June 2022

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

ACI1021007A

05 February 2024

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

QX1019008-A

24 June 2022

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

QX1019010-B

05 December 2022

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

QX1019009-B

05 December 2022

AURO-LOSARTAN HCT 100/25 mg

Auro Pharma Inc.

02423669

QX1019011-A

12 December 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019002-A

May 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019001-A

May 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019003-A

May 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019004-A

May 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019008-A

July 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019007-B

July 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019009-C

December 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

ACO1021003AR

February 2024

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

ACO1021001B

February 2024

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

ACO1021002A

February 2024

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019005-A

May 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019006-A

July 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019007-A

July 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

QY1019009-B

December 2022

LOSARTAN HCT 100/12.5 mg

Sivem Pharmaceuticals ULC

02388979

ACO1021001A

February 2024

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019001-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019002-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019005-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019004-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019003-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019010-A

December 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019009-C

December 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

ACI1021005B

February 2024

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

ACI1021006A

February 2024

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019006-A

June 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

QX1019009-A

December 2022

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

ACI1021005A

February 2024

LOSARTAN HCT 100/25 mg

Sivem Pharmaceuticals ULC

02388987

ACI1021004A

February 2024

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019001-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019002-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019003-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019008-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019007-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019005-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019006-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019004-A

June 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019010-B

December 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

ACI5021007A

February 2024

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

ACI5021005A

February 2024

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

ACI5021006A

February 2024

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

ACI5021004B

February 2024

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019009-A

December 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

QX5019011-A

December 2022

LOSARTAN HCT 50/12.5 mg

Sivem Pharmaceuticals ULC

02388960

ACI5021004A

February 2024

pms-LOSARTAN 25 mg TABLETS

Pharmascience Inc.

02309750

629303

October 2023

pms-LOSARTAN 25 mg TABLETS

Pharmascience Inc.

02309750

636356

July 2024

pms-LOSARTAN 50 mg TABLETS

Pharmascience Inc.

02309769

629302

September 2023

pms-LOSARTAN 50 mg TABLETS

Pharmascience Inc.

02309769

636348

June 2024

pms-LOSARTAN 50 mg TABLETS

Pharmascience Inc.

02309769

636357

June 2024

pms-LOSARTAN 100 mg TABLETS

Pharmascience Inc.

02309777

629306

September 2023

pms-LOSARTAN 100 mg TABLETS

Pharmascience Inc.

02309777

629307

September 2023

pms-LOSARTAN 100 mg TABLETS

Pharmascience Inc.

02309777

636346

July 2024

pms-LOSARTAN 100 mg TABLETS

Pharmascience Inc.

02309777

636358

July 2024

Également disponible en français

SOURCE Health Canada

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/October2021/15/c0408.html

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting